AzTrials
AzTrials

Alcohol Use Disorder (AUD)AAT-AppNCT05120856

AAT-App Outpatient Trial

A study testing AAT-App and Minimal AAT-App in people with Alcohol Use Disorder (AUD), run by Turning Point at 6 sites in Australia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cognitive biases contribute to the difficulty experienced by heavy drinkers wishing to reduce their alcohol use. Recent interventions designed to reduce cognitive biases demonstrate efficacy for Approach Bias Modification (ApBM). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Alcohol Use Disorder (AUD)
What is being tested?
AAT-App and Minimal AAT-App
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
82 participants
Where
6 sitesAustralia
Study dates
25 May 2022to 15 May 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Own an Android or iOS smartphone with an Australian mobile number.
  • Be currently accessing outpatient treatment for alcohol problems. Participants with multiple drugs of concern are eligible as long as alcohol is one of the drugs of concern for the current episode of treatment.
  • Have an Alcohol Use Disorders Identification Test (AUDIT) score of at least 8.

Who cannot join

  • Any residential rehabilitation within the past 4 weeks.
  • Any form of inpatient treatment (e.g. hospital or residential withdrawal treatment) within the past week.
  • Scheduled to enter inpatient/residential treatment within the next month.

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

Australia6 sites
  • Uniting Vic Tas

    Coburg, Victoria, 3058

  • Monash Health (Addiction Medicine Unit)

    Dandenong, Victoria, 3175

  • St. Vincent's Hospital Melbourne (Department of Addiction Medicine)

    Fitzroy, Victoria, 3065

  • Odyssey House Victoria

    Richmond, Victoria, 3121

  • Turning Point

    Richmond, Victoria, 3121

  • Star Health

    South Melbourne, Victoria, 3205

Other trials in Australia

About this study

Official title: AAT-App Trial: A Clinical Trial of a "Brain-training" Smartphone App to Help Reduce Alcohol Use in People Accessing Outpatient Alcohol Treatment

Cognitive biases contribute to the difficulty experienced by heavy drinkers wishing to reduce their alcohol use. Recent interventions designed to reduce cognitive biases demonstrate efficacy for Approach Bias Modification (ApBM). Reductions in the likelihood of relapse have been found after ApBM in Alcohol Use Disorder (AUD) patients during residential treatment. Current methods of ApBM are usually delivered by computer and joystick and come with several limitations, including accessibility. If ApBM could be shown to be feasible in other settings, such as outpatient treatment, it could benefit a much larger population with AUD.

This randomised controlled trial will test the efficacy of a recently-developed ApBM smartphone app called "AAT-App" ("Alcohol Avoidance Training App"). We aim to test whether AAT-App, relative to a minimal version of the app which excludes ApBM training, is effective at reducing alcohol use, cravings, severity of dependence, and approach bias (a measure of a person's automatic tendency to automatically approach alcohol-related stimuli), and to explore user experiences of AAT-App to guide future improvements to the app and its implementation.

Read the detailed description

Aims:

We aim to determine whether providing the "active" version of AAT-App (including ApBM) to people accessing outpatient alcohol treatment from AOD services, is effective, relative to a minimal version of the app which does not include ApBM training, at reducing alcohol use, cravings, and severity of dependence. We also aim to test the psychometric properties of the mobile phone approach bias measure we developed, and whether engaging in AAT-App significantly reduces approach bias, relative to the minimal control condition. We also aim to explore user experiences of AAT-App's, perceived alignment with treatment, and suggested improvements, using qualitative interviews in a subset of participants, to guide further future improvements to the app and its implementation.

Design \& Setting:

We will conduct a double-blind, randomised, parallel-group controlled superiority trial with alcohol treatment outpatients in Melbourne, Victoria. Participants will be randomised to one of 2 groups with a 1:1 allocation ratio. Both participants and researchers completing the follow-up interviews will be unaware (blinded) of the condition to which they have been randomly allocated.

Recruitment:

Staff at participating services will briefly explain the opportunity to participate in a study testing a "brain-training" app to clients who they believe may meet eligibility criteria. To preserve blinding, no specific details will be provided regarding approach bias modification, and participants will merely be informed that the study tests "a new smartphone 'brain-training app'" that "involves doing brief game-like tasks on your phone each week for 4 weeks". Clients who are interested will need to provide consent to be contacted by the research team, who will conduct screening for eligibility, provide more complete participant information, and conduct recruitment.

Screening:

Research staff will phone clients who have provided consent to be contacted to confirm eligibility (administering the Alcohol Use Disorders Identification Test (AUDIT), checking age and phone operating system, confirming that they have no plans to enter residential/inpatient treatment in the next month, confirming absence of past-month residential rehabilitation and any past-week inpatient treatment (e.g., hospitalisation or residential withdrawal), as well as asking about number of days spent in inpatient treatment in the past month if the person underwent any inpatient treatment prior to the previous week).

Randomisation and blinding of allocation:

Six computer-generated randomisation sequences (one for each recruitment site) will be produced by a data scientist who is not otherwise involved in recruitment or data collection, processing, or analysis, using a 1:1 allocation ratio, based on blocks of variable size (ranging from 2-6). As such, randomisation will be stratified by site. The app developers (ANT Development Studios Ltd.) will provide the data scientist with two lists of app access codes which will direct participants to either the intervention or minimal version of AAT-App when they first download and open the app. Using these lists and the randomisation sequence, the data scientist will generate a separate spreadsheet of access codes for each site (based on the site-stratified randomisation sequence). Researchers will send these codes to participants as they are recruited from each respective site. Researchers involved in recruitment will only have access to a spreadsheet displaying a single list of codes to be sent to participants at each respective site, while the randomisation sequence will be stored in a password-protected file provided to the trial statistician and to one research officer who will remain unblinded to assist with coordinating qualitative interviews. Neither the randomisation file, nor its password will be provided to any other staff involved in recruitment or in pursuing follow-ups or quantitative data management until all data analysis is complete.

Data collection windows for post-intervention and follow up assessments:

  1. Post-intervention (28 days post-baseline): Participants will be provided with an in-app link to a Qualtrics survey, in which the link will expire if the survey is not completed within 7 days (i.e., 28-35 days post-baseline).
  2. 1-month follow up (56 days post-baseline): Participants will be prompted with an app notification reminder to report their past-month alcohol consumption via the in-app calendar and complete a Qualtrics survey, in which the link will expire after 2 weeks (i.e., 56-70 days post-baseline).
  3. 3-month follow up (112 days post-baseline): Participants will be prompted with an app notification reminder to report their past-month alcohol consumption and complete a Qualtrics survey, in which the link will expire after 28 days (i.e.,112-140 days post-baseline).

Statistical analyses:

Primary outcome: A linear mixed-effects model (LMM) will be used to compare change in mean standard drinks consumed per week between groups across 4 time points (baseline, post-intervention, 1-month follow-up, and 3-month follow-up). This model will test the main effects of time and group and (most crucially for determining efficacy) the group x time interaction. Planned follow-up comparisons between groups at post-intervention, 1-month follow-up, and 3-month follow-up time-points will be conducted using t-tests, with post-intervention being the primary endpoint. A secondary sensitivity analysis will be conducted excluding a participant's data from any time-point where they had been in residential/inpatient treatment in the past week (i.e., restricting analyses to time-points where a participant's opportunity to drink had not been limited by hospitalisation, rehabilitation, etc.). If a difference between groups is found post-intervention, a secondary LMM analysis of difference between groups in change in weekly standard drinks during the intervention period (i.e., 5 levels of time: Baseline, week 1, week 2, week 3, post-intervention) will be conducted to examine how quickly differences between groups emerge, with t-tests used to compare groups at week 1, 2, 3, and post-intervention time-points. This secondary analysis will be conducted excluding participants who had engaged in any residential/inpatient treatment within the intervention period.

Secondary outcomes: Continuous outcome variables (Craving Experience Questionnaire frequency scale (CEQ-F) scores, Severity of Dependence Scale scores, AUDIT scores, past-week heavy drinking days (HDDs), past-month drinking days, Australian Treatment Outcome Profile quality of life items, and approach bias) will be analysed in a similar manner to the primary analysis described above. Sensitivity analysis of past-week drinking days to control for the possible effect of past-week residential/inpatient treatment will be conducted as described for the primary outcome. Past-month drinking days will be expressed as a percentage of the total number of days on which a participant had the opportunity to drink (i.e., if a participant was in residential/inpatient treatment for 10 days at a certain time point, then for that time point, their past-month drinking days will be expressed as a proportion of the remaining 18 days on which they had the opportunity to drink), although data will be excluded at any time point where the participant did not have at least 14 days on which they had the opportunity to drink alcohol (i.e., if they were within residential/inpatient treatment on 15 or more days). For CEQ-F, secondary analyses will be conducted for each of its 3 subscales. Analyses of AUDIT scores will use 2 levels of time (baseline, 3-month follow-up). Approach bias analyses will also use 2 levels of time (baseline, post-intervention) and approach bias scores will be analysed separately for alcohol and positive images. As past-month HDDs can only be calculated at 1 time point (post-intervention), they will simply be compared between groups using a t-test post-intervention after converting scores to a proportion of days on which the participant had an opportunity to drink (as described for past-month drinking days). Proportions of groups reporting complete past-week and past-month abstinence will be compared between groups at post-intervention, 1-month follow-up, and 3-month follow-up using Pearson's chi-squared. Mobile Application Rating Scale 'functionality', 'aesthetics', and 'subjective quality' scores, and participants' subjective ratings regarding AAT-App's effect on drinking and cravings will be explored within each group separately using descriptive data (e.g., mean, median, quartile cut-offs, percentages scoring above 3) to quantify typical ratings and proportions of participants providing favourable ratings. Where relevant, exploratory analyses will also compare mean scores of uMARS scales between groups using t-tests.

Qualitative study:

Interview transcripts will be subjected to a thematic qualitative analysis in order to identify underlying themes and patterns within each respondent's discourse. Thematic analysis will proceed according to the six stage process described by Braun and Clark. The coding process will be primarily conducted by two researchers, and a third researcher will oversee and verify coding decisions to ensure agreement and consistency throughout the process. The digital qualitative data analysis software NVivo 11.4.0 will be used to facilitate qualitative data analysis. Free-text responses to app acceptability questions in the post-intervention survey will be reviewed primarily to identify reports of functionality issues (e.g., "bugs" in the app) and safety issues (e.g., reports of triggering). Any such issues will be catalogued to inform further improvements to the app (if necessary) and its delivery/implementation in future research and/or treatment contexts.

Being tested
AAT-App, Minimal AAT-App
Keywords
Approach Bias Modification, Alcohol, Alcohol Use Disorder, Addiction, Cognitive Bias Modification, mHealth, Smartphone App
Medical subject headings
Alcoholism, Behavior, Addictive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AAT-AppBehavioural

    Participants will receive the active AAT-App on their smartphone, which includes ApBM training, and prompted to engage with the app during the 28-day intervention period.

  • Minimal AAT-AppBehavioural

    Participants will receive the minimal version of AAT-App, which does not include ApBM training, on their smartphone and prompted to engage with the app during the 28-day intervention period.

Study groups in NCT05120856
Study groupRoleWhat they receive
Active AAT-AppExperimentalParticipants will receive the active AAT-App.
Receives: Behavioral: AAT-App
Minimal AAT-AppSham comparatorParticipants will receive the minimal version of AAT-App.
Receives: Behavioral: Minimal AAT-App

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Standard Drinks Consumed Per Week

    Participants will estimate the number of standard drinks of alcohol consumed on each day within the past week, using a timeline follow-back assessment. Participants will select a number, ranging from 0-80, to estimate how many standard drinks they consumed on each day in that week. Past-week standard drinks will be calculated using the sum of values for each of the past 7 days.

    Measured: Baseline, 4 weeks after commencing app use, 8 weeks after commencing app use, and 16 weeks after commencing app use

Secondary outcomes (9)
  1. Past-Week Frequency of Alcohol Cravings (as Measured by the Craving Experience Questionnaire Frequency Scale - CEQ-F)

    The Craving Experience Questionnaire frequency scale (CEQ-F) is a validated, 10-item scale, with each item rated on a scale of 0-10. Total scores are calculated based on the mean of individual items. Higher scores indicate more frequent craving experiences. Three subscale scored can also be calculated: "intensity" (3 items), "imagery" (4 items), and "intrusiveness" (3 items). Secondary analyses will be conducted for each of its 3 subscales.

    Measured: Baseline, 4 weeks after commencing app use, 8 weeks after commencing app use, and 16 weeks after commencing app use

  2. Severity of Dependence Scale (SDS) Scores

    The Severity of Dependence Scale (SDS) is a validated, 5-item scale, with each item scored 0-3. Total scores are calculated by summing individual item scores. Higher scores indicate more severe psychological dependence on the drug being enquired about (i.e., alcohol in this study)

    Measured: Baseline, 4 weeks after commencing app use, 8 weeks after commencing app use, and 16 weeks after commencing app use

  3. Total Scores on the Alcohol Use Disorders Identification Test (AUDIT)

    The Alcohol Use Disorders Identification Test (AUDIT) is a validated, 10-item scale, with each item scored 0-4. Total scores are calculated based on the sum of individual item scores. Given the AUDIT usually enquires about drinking and related problems in the past year, wording of instructions and questions was modified to ask participants to base answers on the past 3 months so that equivalent, non-overlapping periods were assessed at both baseline and the final follow-up.

    Measured: Baseline and 16 weeks after commencing app use

  4. Past-week Heavy Drinking Days (HDDs)

    Participants estimated the number of standard drinks of alcohol consumed on each day within the past week. Any day when they estimate they consumed at least 5 standard drinks in a day was considered an HDD.

    Measured: Baseline, 4 weeks after commencing app use, 8 weeks after commencing app use, and 16 weeks after commencing app use

  5. Past-Month Drinking Days

    At baseline, participants will complete the past-week drinking assessment described above and also report number of drinking days in each of the 3 weeks preceding the past week. 1-month and 3-month follow-up assessments will be identical to the baseline assessment.

    Measured: Baseline, 8 weeks after commencing app use, and 16 weeks after commencing app use

  6. Proportion of Past-Week Complete Abstinence at Post-Intervention and Follow Up Assessments

    Past-week complete abstinence will be defined as zero days in the past week on which any alcohol was consumed. Predicted proportions from the linear mixed-effects model are entered using a measure type of "mean", as advised by the trial statistician, because the model produces predicted means from the data (after coding abstinence as 1 and non-abstinence as 0) after the model accounts for complexities in the data, such as the repeated measures of the data, imbalances in group sizes, and assumptions regarding error correlation, random effects, fixed effects.

    Measured: Baseline, 4 weeks after commencing app use, 8 weeks after commencing app use, and 16 weeks after commencing app use

  7. Proportion of Past-Month Complete Abstinence at Post-Intervention and Follow Up Assessments

    Participants reporting zero drinking days in the past month will be classified as past-month abstinent. Predicted proportions from the linear mixed-effects model are entered using a measure type of "mean", as advised by the trial statistician, because the model produces predicted means from the data (after coding abstinence as 1 and non-abstinence as 0) after the model accounts for complexities in the data, such as the repeated measures of the data, imbalances in group sizes, and assumptions regarding error correlation, random effects, fixed effects.

    Measured: Baseline, 8 weeks after commencing app use, and 16 weeks after commencing app use

  8. Scores for Quality of Life and Health Items on the Australian Treatment Outcomes Profile (ATOP)

    3 items will be adapted from the Australian Treatment Outcomes Profile (ATOP) assessing psychological health, physical health, and overall quality of life over the past 28 days. Each item will be rated on a scale from zero to ten, where zero is poor and ten is good. Each rating will be treated as a separate variable in analyses (i.e., no composite score will be derived from the 3 separate items).

    Measured: Baseline, 4 weeks after commencing app use, 8 weeks after commencing app use, 16 weeks after commencing app use.

  9. Approach Bias

    Approach bias will be assessed within the app using an alcohol approach avoidance task. The approach avoidance task is a behavioural task designed to measure alcohol approach bias, which is the tendency to approach alcohol-related stimuli more quickly than avoiding them (relative to the same tendency for neutral stimuli). This is calculated from reaction time differences according to the formula: (RTalc-avoid - RTalc-approach) - (RTneu-avoid - RTneu-approach), where RTs are the mean reaction times for alcohol avoidance, alcohol approach, neutral stimulus avoidance, and neutral stimulus approach reactions, respectively. Thus, a positive approach bias score reflects a tendency to make an approach movement towards alcohol images more quickly than to make an avoidance, and for that tendency to be larger than the equivalent tendency for neutral images. Scores do not have specific minimum or maximum values.

    Measured: Baseline and Post-Intervention (28 days after commencing app use)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Nov 2021
  2. Study start25 May 2022
  3. Primary completion21 Feb 2024
  4. Study completion15 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A double-blind, randomised, parallel-group controlled superiority trial with alcohol treatment outpatients will be conducted. Participants will be randomised to one of 2 groups with a 1:1 allocation ratio.
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
82 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05120856
Sponsor's protocol ID
ADRIA045
Acronym
AAT-App
Status last verified
May 2024
First submitted
22 Oct 2021
Last updated
16 Dec 2024
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: There is no plan to grant general public access to the dataset. Researchers interested in accessing deidentified individual-level participant data may contact the coordinating principal investigator, Victoria Manning. Granting access to other researchers to use deidentified data will require additional approval by the Saint Vincent's Hospital Melbourne Human Research Ethics Committee, and seeking these approvals will be the responsibility of the researchers seeking access to the dataset.

Publications

  • Eberl C, Wiers RW, Pawelczack S, Rinck M, Becker ES, Lindenmeyer J. Approach bias modification in alcohol dependence: do clinical effects replicate and for whom does it work best? Dev Cogn Neurosci. 2013 Apr;4:38-51. doi: 10.1016/j.dcn.2012.11.002. Epub 2012 Nov 14.

    PubMed 23218805
  • Manning V, Staiger PK, Hall K, Garfield JB, Flaks G, Leung D, Hughes LK, Lum JA, Lubman DI, Verdejo-Garcia A. Cognitive Bias Modification Training During Inpatient Alcohol Detoxification Reduces Early Relapse: A Randomized Controlled Trial. Alcohol Clin Exp Res. 2016 Sep;40(9):2011-9. doi: 10.1111/acer.13163. Epub 2016 Aug 4.

    PubMed 27488392
  • Manning V, Garfield JBB, Staiger PK, Lubman DI, Lum JAG, Reynolds J, Hall K, Bonomo Y, Lloyd-Jones M, Wiers RW, Piercy H, Jacka D, Verdejo-Garcia A. Effect of Cognitive Bias Modification on Early Relapse Among Adults Undergoing Inpatient Alcohol Withdrawal Treatment: A Randomized Clinical Trial. JAMA Psychiatry. 2021 Feb 1;78(2):133-140. doi: 10.1001/jamapsychiatry.2020.3446.

    PubMed 33146693
  • Rinck M, Wiers RW, Becker ES, Lindenmeyer J. Relapse prevention in abstinent alcoholics by cognitive bias modification: Clinical effects of combining approach bias modification and attention bias modification. J Consult Clin Psychol. 2018 Dec;86(12):1005-1016. doi: 10.1037/ccp0000321.

    PubMed 30507226
  • Salemink E, Rinck M, Becker E, Wiers RW, Lindenmeyer J. Does comorbid anxiety or depression moderate effects of approach bias modification in the treatment of alcohol use disorders? Psychol Addict Behav. 2022 Aug;36(5):547-554. doi: 10.1037/adb0000642. Epub 2021 Jun 10.

    PubMed 34110839
  • Wiers RW, Eberl C, Rinck M, Becker ES, Lindenmeyer J. Retraining automatic action tendencies changes alcoholic patients' approach bias for alcohol and improves treatment outcome. Psychol Sci. 2011 Apr;22(4):490-7. doi: 10.1177/0956797611400615. Epub 2011 Mar 9.

    PubMed 21389338
  • Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006; 3(2): 77-101.

  • Manning V, Bell MCL, Garfield JBB, Paxie JCB, Rubenis A, Roxburgh AD, Piercy H, Whelan D, Lubman DI, Savic M. "A tool in a toolbox": patient engagement with a gamified and personalised approach bias modification app to reduce harmful alcohol consumption - a qualitative study. Addict Sci Clin Pract. 2026 Jan 31;21(1):22. doi: 10.1186/s13722-026-00646-6.

    PubMed 41620760
  • Garfield JBB, Rowland B, Liu SK, Piercy H, Bonomo Y, Whelan D, Manning V. Efficacy of a personalised alcohol approach bias modification smartphone app in people accessing outpatient alcohol use disorder treatment: A randomised controlled trial. Addiction. 2026 Jan;121(1):82-93. doi: 10.1111/add.70184. Epub 2025 Sep 4.

    PubMed 40905156

Questions about this trial

What is this clinical trial studying?

A study testing AAT-App and Minimal AAT-App in people with Alcohol Use Disorder (AUD), run by Turning Point at 6 sites in Australia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 16 Dec 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Standard Drinks Consumed Per Week (time frame: Baseline, 4 weeks after commencing app use, 8 weeks after commencing app use, and 16 weeks after commencing app use). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05120856, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Dec 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in